Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
about
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.GCPII imaging and cancer.Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alonePET/CT Imaging and Radioimmunotherapy of Prostate CancerPositron emission tomography: clinical applications in oncology. Part 2.Positron emission tomography and molecular imaging of the prostate: an update.Imaging localized prostate cancer: current approaches and new developments.Choline autoradiography of human prostate cancer xenograft: effect of castrationManagement of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.Molecular imaging of prostate cancer: a concise synopsisNew horizons in prostate cancer imaging.Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.PET and PET/CT in radiation treatment planning for prostate cancer.Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.PET imaging in prostate cancer: focus on prostate-specific membrane antigenImaging biomarkers in prostate cancer: role of PET/CT and MRI.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Metabolomics applications in precision medicine: An oncological perspective.Emerging applications of metabolomics in drug discovery and precision medicine.18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer.Giant Schmorl's Node may Cause High Uptake and Mimic a Bone Metastasis on (18)F-Choline Positron Emission Tomography/Computed Tomography.When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer.The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical Oncology.Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment.Kinetic Modeling Application to (18)F-fluoroethylcholine Positron Emission Tomography in Patients with Primary and Recurrent Prostate Cancer Using Two-tissue Compartmental Model.Synthetic approach for unsaturated precursors for parahydrogen induced polarization of choline and its analogs.Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?Introducing parametric fusion PET/MRI of primary prostate cancer.The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT.
P2860
Q33583831-D078D7AA-8636-4EA5-B383-313C6DA11810Q33827632-929F5EB2-E34A-4103-8A52-16DE02937B58Q34557038-DE3C3FDF-C8EC-45EA-AABD-321EAF47B8DFQ35964874-03B3C50B-7E1A-49DC-882C-2CBFFB0A158EQ36085426-88AE443D-74F8-4DBA-8432-2807995A8353Q36448703-72D404BF-9D77-488C-BD81-E4EEACD26C09Q36462108-16D287B9-39DC-4539-92AE-00BEEB4DBAC6Q36469177-D252C2C6-E9B5-4EEA-9E78-DF3ECF02D53AQ37052606-867F7300-F96E-4354-9C3C-40AFAC1829F4Q37086178-6BF168ED-AB38-4905-A0DC-BD93F8466130Q37207397-1B261170-43D8-4E4E-A555-18E8FE100793Q37242030-0F40F86B-C3E2-48E4-A17D-34A3E5963034Q37714485-FE7948B7-FEBB-4A72-9D36-C8FE8C2DD6A5Q37878465-1A77CAD3-220F-4115-A6FD-B8D75CBC278FQ37909361-0100881B-2CCC-40D4-AB10-04C43FEADEBDQ38098124-5BC789C3-D622-4CFD-8D0F-B8EEA65DA7A1Q38098441-B9D0C9C5-2CD4-4018-9764-420B7D82A2E2Q38099369-3CE06DBB-BC4F-4A5C-895A-A9044A0612ABQ38321182-F2713429-958A-4ACF-B44E-E15928B642F9Q38564109-3E07A291-54ED-4786-A228-CB1A8B58B998Q38689857-68E48BAB-B7C8-402C-85F4-7FA5275F30A8Q38769103-2105BACE-F99A-45A7-BAC2-797204578FC1Q38924757-F5E6F98E-D613-4A98-AEB4-D30E42E49D13Q39512219-8457E9DE-4EBE-4505-AC36-D2F6AAD56B1BQ39601617-B5B85BFB-A43E-412D-BF09-8F809B9C636DQ39636721-C7B62C42-E564-4EF4-A08A-22CD5312897DQ42066553-48C65FE7-D804-403A-9547-97C04040BA74Q42088489-C243800F-9965-4876-B644-FE3693FF2348Q42124600-77B7079F-CBB0-409A-808E-BEFD3722BF83Q42199666-BEE7D58A-4FC8-455D-A636-C1DD9968D882Q42423216-88485BD5-78C3-4B57-BC52-BA5AD8C0A899Q42716680-5BFA1F11-0864-4B93-9BD0-11D80A1C636BQ42842341-00A4D6A2-EC87-4693-823E-FEAA39662DFDQ42871596-4FAEE5FD-29CA-4905-BBF0-989CBF9F0A45Q43478484-E29224E9-D22F-4844-83D1-DBB5E34AA4D8Q44322324-510CA073-7E59-4872-8C13-D83BAB1BB716Q44638163-4407F877-F5C8-450B-AC85-FB34F0F1ED4BQ46813213-09165E24-30DB-47D1-99BB-BA044AC85201Q48347188-6312C501-D06E-4536-BF6B-8BA7EC99030FQ49318705-50E9F863-F9A2-4E94-9178-966DF6E7E548
P2860
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Kinetics of [
@nl
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
@en
type
label
Kinetics of [
@nl
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
@en
prefLabel
Kinetics of [
@nl
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
@en
P2093
P1476
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study
@en
P2093
Eija Sutinen
Martti Nurmi
Matti Varpula
Pertti Lehikoinen
Tuula Tolvanen
P2888
P304
P356
10.1007/S00259-003-1377-9
P577
2003-11-20T00:00:00Z